Grosse to take over as Group CEO on July 1, 2025 Göttingen — At its meeting today, the Supervisory Board of Sartorius AG appointed Dr. Michael Grosse Chief Executive Officer of Sartorius. He will take over this position on July 1, 2025, from Dr. Joachim Kreuzburg, who will continue to lead the company until that […]
Multiplexed, extraction-free, full-length library preparation technology facilitates large-scale RNA sequencing, combining ever more content with high throughput LAUSANNE, Switzerland — Alithea Genomics, a leader in the field of large-scale RNA sequencing and transcriptomics, announced today the launch of MERCURIUS™ Full-Length DRUG-seq library preparation technology, which combines, for the first time, massive sample multiplexing, an extraction-free […]
Today we celebrated the opening of our global capability center in Bengaluru, India, to grow its global workforce, deepen technology talent in the region, and support a global customer base. The Illumina office is located within Bengaluru’s Manyata Technology Park, a complex shared among global technology, health care, and biopharma companies. More than 80 Illumina […]
Carl Hull to Retire as Executive Chairman SAN DIEGO — Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced that Carl Hull will retire from his position as Executive Chairman of the Board and that the Board of Directors has […]
PISCATAWAY, N.J. — GenScript Biotech, a global biotechnology leader in the life science, biologics manufacturing, synthetic biology, and cell therapies announced today that its Life Sciences subsidiary, GenScript, has launched a next generation DNA purification platform: The AmMag™ Quatro Mini-1100. This new instrument complements the widely acclaimed AmMag Quatro Maxi-1400, providing comprehensive solutions for both mini- and maxi-scale plasmid […]
Agreement grants access to Synaffix patent portfolio related to metal-free click chemistry Technology to be used in Illumina’s next-generation sequencing (NGS) products AMSTERDAM — Synaffix B.V., a Lonza company (SIX:LONN) focused on commercializing its clinical-stage bioconjugation platform technology for the development of antibody-drug conjugates (ADCs) with best-in-class therapeutic index and beyond, today announced it has entered […]
HATFIELD, Pa. — Biolyst Scientific, a leader in electron microscopy, histology and life sciences, is excited to announce a strategic growth initiative that will strengthen its position in the industry and empower future growth. As part of this transformation, the company has recruited its founding visionaries, Reza Ardekani and Stacie Kirsch to form an advisory board, along with Adam Ardekani who served […]
Oxford, UK – Today, OGT announced the launch of its newly updated NGS SureSeq™ CLL + CNV V3 Panel which further incorporates the company’s highly sensitive proprietary bait designs to offer more expansive coverage of disease-associated genes and enhanced CNV detection. This new panel now offers users more comprehensive variant detection to improve confidence in classification of CLL […]
The implementation of MGI Tech’s next-generation genomic sequencing (NGS) technologies will strengthen scientific research in the country, enabling the identification of key genetic variations, contributing to disease prevention, and personalizing medical treatments. A team of specialists from USMP will work on advancing five research projects focused on rare diseases, infectious diseases, cancer, pharmacogenomics as well as understanding […]
With a deep understanding of Sales and working with top pharmaceutical companies, Mark will lead the Commercial team as it sets it sights on growth in 2025. Zetta’s mission of unlocking the potential of genomic data to transform healthcare aligns with my passion for advancing science through cutting-edge technology.” — Dr. Mark Hughes CAMBRIDGE, CAMBRIDGESHIRE, […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
